Our CDO, Mark Farmery, is attending this European cell and gene therapy congress for manufacturing, commercialisation and supply chain strategies. He will be presenting Anocca’s industrialised platform as part of the “Gene edited ex vivo cell therapy” track on December 7th.

 

< Back to newsroom